Literature DB >> 25675265

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).

P W Andrews1, D Baker, N Benvinisty, B Miranda, K Bruce, O Brüstle, M Choi, Y-M Choi, J M Crook, P A de Sousa, P Dvorak, C Freund, M Firpo, M K Furue, P Gokhale, H-Y Ha, E Han, S Haupt, L Healy, D J Hei, O Hovatta, C Hunt, S-M Hwang, M S Inamdar, R M Isasi, M Jaconi, V Jekerle, P Kamthorn, M C Kibbey, I Knezevic, B B Knowles, S-K Koo, Y Laabi, L Leopoldo, P Liu, G P Lomax, J F Loring, T E Ludwig, K Montgomery, C Mummery, A Nagy, Y Nakamura, N Nakatsuji, S Oh, S-K Oh, T Otonkoski, M Pera, M Peschanski, P Pranke, K M Rajala, M Rao, R Ruttachuk, B Reubinoff, L Ricco, H Rooke, D Sipp, G N Stacey, H Suemori, T A Takahashi, K Takada, S Talib, S Tannenbaum, B-Z Yuan, F Zeng, Q Zhou.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25675265     DOI： 10.2217/rme.14.93

Source DB:  PubMed          Journal:  Regen Med        ISSN： 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  31 in total

1.  First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine.

Authors:  Kunie Sakurai; Andreas Kurtz; Glyn Stacey; Michael Sheldon; Wataru Fujibuchi
Journal:  Stem Cells Transl Med       Date:  2016-07-12       Impact factor: 6.940

2.  Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations.

Authors:  Qi Gu; Juan Wang; Lei Wang; Zheng-Xin Liu; Wan-Wan Zhu; Yuan-Qing Tan; Wei-Fang Han; Jun Wu; Chun-Jing Feng; Jin-Hui Fang; Lei Liu; Liu Wang; Wei Li; Xiao-Yang Zhao; Bao-Yang Hu; Jie Hao; Qi Zhou
Journal:  Stem Cell Reports       Date:  2017-05-11       Impact factor: 7.765

3.  Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.

Authors:  Alexander Kondrashov; Minh Duc Hoang; James G W Smith; Jamie R Bhagwan; Gary Duncan; Diogo Mosqueira; Maria Barbadillo Munoz; Nguyen T N Vo; Chris Denning
Journal:  Stem Cells Dev       Date:  2018-03-12       Impact factor: 3.272

4.  High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells.

Authors:  Matteo D'Antonio; Grace Woodruff; Jason L Nathanson; Agnieszka D'Antonio-Chronowska; Angelo Arias; Hiroko Matsui; Roy Williams; Cheryl Herrera; Sol M Reyna; Gene W Yeo; Lawrence S B Goldstein; Athanasia D Panopoulos; Kelly A Frazer
Journal:  Stem Cell Reports       Date:  2017-04-11       Impact factor: 7.765

Review 5.  Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells.

Authors:  Leili Rohani; Adiv A Johnson; Pooyan Naghsh; Derrick E Rancourt; Henning Ulrich; Heidrun Holland
Journal:  Stem Cells Transl Med       Date:  2018-09-14       Impact factor: 6.940

6.  Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.

Authors:  Jung-Hyun Kim; Andreas Kurtz; Bao-Zhu Yuan; Fanyi Zeng; Geoff Lomax; Jeanne F Loring; Jeremy Crook; Ji Hyeon Ju; Laura Clarke; Maneesha S Inamdar; Martin Pera; Meri T Firpo; Michael Sheldon; Nafees Rahman; Orla O'Shea; Patricia Pranke; Qi Zhou; Rosario Isasi; Ruttachuk Rungsiwiwut; Shin Kawamata; Steve Oh; Tenneille Ludwig; Tohru Masui; Thomas J Novak; Tsuneo Takahashi; Wataru Fujibuchi; Soo Kyung Koo; Glyn N Stacey
Journal:  Stem Cells Transl Med       Date:  2017-10-24       Impact factor: 6.940

Review 7.  Induced pluripotent stem cells, a giant leap for mankind therapeutic applications.

Authors:  José Bragança; João André Lopes; Leonardo Mendes-Silva; João Miguel Almeida Santos
Journal:  World J Stem Cells       Date:  2019-07-26       Impact factor: 5.326

Review 8.  Recognizing the ethical implications of stem cell research: A call for broadening the scope.

Authors:  Lars S Assen; Karin R Jongsma; Rosario Isasi; Marianna A Tryfonidou; Annelien L Bredenoord
Journal:  Stem Cell Reports       Date:  2021-07-01       Impact factor: 7.765

9.  cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.

Authors:  Behnam Ahmadian Baghbaderani; Xinghui Tian; Boon Hwa Neo; Amy Burkall; Tracy Dimezzo; Guadalupe Sierra; Xianmin Zeng; Kim Warren; Don Paul Kovarcik; Thomas Fellner; Mahendra S Rao
Journal:  Stem Cell Reports       Date:  2015-09-24       Impact factor: 7.765

10.  Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells.

Authors: 
Journal:  Nat Commun       Date:  2018-05-15       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.